PlainRecalls
CriticalClass IOngoing

FDA Devices recall · Reported February 28, 2024

Baxter Exactamix Pro 2400, REF EXM24DY

An error was identified in software versions 2.0.8 and 2.1.8 while using the "Use Some Overfill" feature which may lead to over-delivery of an ingredient. This issue can result in…

Recall #
Z-1002-2024
Affected scope
67 devices
Initiated
December 22, 2023
Verify with FDA Devices →
View my saved recalls

Baxter Healthcare Corporation recalled Baxter Exactamix Pro 2400, REF EXM24DY - a critical-severity action.

Baxter Exactamix Pro 2400, REF EXM24DY was recalled by Baxter Healthcare Corporation in February 28, 2024. Reason: An error was identified in software versions 2.0.8 and 2.1.8 while using the "Use Some Overfill" feature whic…. Check the official notice for the remedy. Verify recall #Z-1002-2024 with the FDA Devices before acting.

The recall

Baxter Healthcare Corporation issued this critical-severity FDA Devices recall-An error was identified in software versions 2.0.8 and 2.1.8 while using the "Use Some Overfill" feature whic….

Critical
severity level
67 units
affected scope
Class I
classification
February 28, 2024
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-1002-2024 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 41,021 medical devices recalls on record

01,0002,0003,0004,000 20052008201120142017202020232026 1,947
Severity1906864652High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified high severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Baxter Exactamix Pro 2400, REF EXM24DY

Reason for recall

An error was identified in software versions 2.0.8 and 2.1.8 while using the "Use Some Overfill" feature which may lead to over-delivery of an ingredient. This issue can result in redundant ingredient delivery of the requested overfill volume.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Critical (Class I)
Status Ongoing
Recall number Z-1002-2024
Date reported February 28, 2024
Date initiated December 22, 2023
Recalling firm Baxter Healthcare Corporation
Firm location Deerfield, IL
Affected scope 67 devices
Distribution US: AL, AZ, CA, FL, GA, IA, KY, MD, MI, MN, MO, NC, NE, NH, NJ, NV, NY, OR, SD, TX, WA, WI,

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

Scale of Impact

67 devices units affected - limited or regional distribution scale.

Regional (<10K units) ✓ This recall
Multi-state (10K – 100K units) -
Large-scale (100K – 1M units) -
Massive (≥1M units) -

Bracket cutoffs follow federal recall-disclosure conventions; bar widths scale linearly within each bracket. Source: PlainRecalls analysis of U.S. Food and Drug Administration filings.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-1002-2024) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Baxter Exactamix Pro 2400, REF EXM24DY. Recalled by Baxter Healthcare Corporation. Units affected: 67 devices.
Why was this product recalled?
An error was identified in software versions 2.0.8 and 2.1.8 while using the "Use Some Overfill" feature which may lead to over-delivery of an ingredient. This issue can result in redundant ingredient delivery of the requested overfill volume.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 28, 2024. Severity: Critical. Recall number: Z-1002-2024.
Where was the recalled product distributed?
Distribution: US: AL, AZ, CA, FL, GA, IA, KY, MD, MI, MN, MO, NC, NE, NH, NJ, NV, NY, OR, SD, TX, WA, WI,.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Compare this recall with GORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VS… → · All Medical Devices recalls

This recall: FDA Devices, reported February 28, 2024. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026